Extremely high mutation rate of HIV-1 in vivo JM Cuevas, R Geller, R Garijo, J López-Aldeguer, R Sanjuán PLoS biology 13 (9), e1002251, 2015 | 488 | 2015 |
Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units M Combe, R Garijo, R Geller, JM Cuevas, R Sanjuán Cell host & microbe 18 (4), 424-432, 2015 | 98 | 2015 |
Highly heterogeneous mutation rates in the hepatitis C virus genome R Geller, Ú Estada, JB Peris, I Andreu, JV Bou, R Garijo, JM Cuevas, ... Nature Microbiology 1 (7), 1-7, 2016 | 54 | 2016 |
Human norovirus hyper-mutation revealed by ultra-deep sequencing JM Cuevas, M Combe, M Torres-Puente, R Garijo, S Guix, J Buesa, ... Infection, Genetics and Evolution 41, 233-239, 2016 | 35 | 2016 |
Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells R Garijo, P Hernandez-Alonso, C Rivas, JS Diallo, R Sanjuan PLoS One 9 (7), e102365, 2014 | 34 | 2014 |
Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decoupling V Furió, R Garijo, M Durán, A Moya, JC Bell, R Sanjuán Journal of Virology 86 (22), 12228-12236, 2012 | 26 | 2012 |
Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1 I García-Alcover, J Colonques-Bellmunt, R Garijo, JR Tormo, R Artero, ... Disease Models & Mechanisms 7 (11), 1297-1306, 2014 | 21 | 2014 |
Constrained evolvability of interferon suppression in an RNA virus R Garijo, JM Cuevas, Á Briz, R Sanjuán Scientific reports 6 (1), 24722, 2016 | 11 | 2016 |
Análisis comparativo de la carga viral mediante bDNA HCV RNA-2.0 y Amplicor HCV Monitor, en pacientes infectados por el virus de la hepatitis C J Córdoba, V Olaso, JM Molina, B López, L Argüello, V Ortiz Enf Infec Microbiol 18, 6-11, 2000 | 8 | 2000 |
Experimental evolution of an RNA virus in cells with innate immunity defects P Hernandez-Alonso, R Garijo, JM Cuevas, R Sanjuan Virus Evolution 1 (1), vev008, 2015 | 6 | 2015 |
Factores de riesgo cardiovascular en pacientes intervenidos de estenosis carotídea en el Hospital 12 de Octubre RM Garijo, MCM Pérez, CB Domínguez, RB Guerrero Revista de Enfermería Vascular 2 (4), 5-9, 2019 | 4 | 2019 |
ROC curve analysis of factors predictive of no response to interferon treatment in patients with chronic hepatitis C, genotype 1 VV Olaso, J Cordoba, MS Siles, JM Molina, RJ Esteban, R Garijo, J Mora, ... Revista espanola de quimioterapia: publicacion oficial de la Sociedad …, 2000 | 2 | 2000 |
Retratamiento con interferón más ribavirina en pacientes con hepatitis crónica C, genotipo 1, no respondedores o con recaída tras un tratamiento previo con interferón … V Olaso, J Córdoba, JM Molina, B López, MS Siles, J Jaén, F Martínez, ... Rev Esp Quimioterap 15 (3), 247-56, 2002 | 1 | 2002 |
Resistencias del VIH-1 y el laboratorio clínico J Córdoba, MG Serrano, R Garijo, RJ Esteban, JM Molina Revista Española de Quimioterapia 12 (4), 4, 1999 | 1 | 1999 |
Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice MC Álvarez-Abril, I García-Alcover, J Colonques-Bellmunt, R Garijo, ... International Journal of Molecular Sciences 24 (12), 9820, 2023 | | 2023 |
Experimental evolution of a p53-specific oncolytic vesicular stomatitis virus R Sanjuan, R Garijo, P Hernandez, C Rivas, JS Diallo HUMAN GENE THERAPY 25 (12), A22-A22, 2014 | | 2014 |
Plan de cuidados en la nefrolitotomía percutánea. A propósito de un caso clínico TMB Sabater, MS Condeminas, MR Peyró, CS Pérez, RM Garijo, ... Enfuro, 27-31, 2013 | | 2013 |
Retreatment with interferon plus ribavirin in chronic hepatitis C patients with genotype 1 who had no response or a relapse with a previous interferon treatment. Long term … V Olaso, J Córdoba, JM Molina, L López, MS Siles, J Jaén, F Martínez, ... Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad …, 2002 | | 2002 |
Análisis mediante curvas ROC de los factores predictivos de no respuestaal tratamiento con interferón en pacientescon hepatitis crónica C genotipo 1 J Córdoba, MS Siles, JM Molina, RJ Esteban, R Garijo, J Mora, D Nicolás, ... Rev. esp. quimioter, 51-59, 2000 | | 2000 |
Comparative analysis of viral load by bDNA HCV RNA-2.0 and amplicor HCV monitor in patients with hepatitis C infection J Córdoba, V Olaso, JM Molina, L Argüello, V Ortiz, RJ Esteban, R Garijo, ... Enfermedades Infecciosas y Microbiologia Clinica 18 (1), 6-11, 2000 | | 2000 |